Faxeladol

DB20529InvestigationalSmall molecule

Faxeladol is a small molecule drug. The usage of the INN stem '-adol/-adol-' in the name indicates that Faxeladol is a analgesic. Faxeladol is under investigation in clinical trial NCT03765801... Faxeladol is under investigation in clinical trial NCT03765801 (A Clinical Study in Healthy Women Which Aims to Explore the Intestinal Uptake of Two Different Tablets of GRTA9906 Into the Body and the Effect of Food...

Mechanism: Pharmacologically active on Sodium-dependent noradrenaline transporter, Sodium-dependent serotonin transporter, and Mu-type opioid receptor
Curator reviewed
Formula / weight: C₁₅H₂₃NO · 233.355 g/mol (avg)
Code names: EM-906 · GCR-9905 · GRTA-0009906 · GRTA-9906 · GRT-TA300

Resolves to

Compound

UNIIC04V6SGK8HCAS433265-65-7ChEMBLCHEMBL2103829

Structure

InChIKeyJIRYWFYYBBRJAN-ZFWWWQNUSA-NSMILESCN(C)C[C@@H]1CCCC[C@H]1C1=CC=CC(O)=C1

Targets

P23975SLC6A2P31645SLC6A4P35372OPRM1

What you can answer from here — as of September 16, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Faxeladol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account